KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Share-based Compensation Growth (5y) (2014 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 13.10%
Sep 30, 2023 6.20%
Jun 30, 2023 5.05%
Mar 31, 2023 -2.74%
Dec 31, 2018 -2.55%
Sep 30, 2018 -5.09%
Jun 30, 2018 -3.65%
Mar 31, 2018 -10.11%
Dec 31, 2017 -1.35%
Sep 30, 2017 -0.67%
Jun 30, 2017 -1.78%
Mar 31, 2017 -4.36%
Dec 31, 2016 -1.50%
Sep 30, 2016 3.17%
Jun 30, 2016 -2.15%
Mar 31, 2016 -7.55%
Dec 31, 2015 -5.29%
Sep 30, 2015 0.00%
Jun 30, 2015 -1.69%
Mar 31, 2015 0.58%
Dec 31, 2014 7.16%
Sep 30, 2014 3.67%
Jun 30, 2014 11.84%
Mar 31, 2014 8.08%